The arrival of Retatrutide ZPHC, at a dosage of 120mg, is generating considerable excitement within the weight loss community. This novel dual GIP and GLP-1 receptor medication seems to offer impressive improvements in body loss compared to current therapies. Preliminary research data have indicated marked reductions in weight , potentially marking